telmisartan has been researched along with Acute Coronary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biasucci, LM; Capogrossi, MC; Crea, F; Dato, I; De Maria, GL; Di Vito, L; Leone, AM; Niccoli, G; Porto, I; Tritarelli, A | 1 |
| Biasucci, LM; Capogrossi, MC; Crea, F; Dato, I; De Maria, GL; Di Vito, L; Leone, AM; Paglia, A; Porto, I; Tritarelli, A | 1 |
2 trial(s) available for telmisartan and Acute Coronary Syndrome
| Article | Year |
|---|---|
Comparison of the effects of ramipril versus telmisartan on high-sensitivity C-reactive protein and endothelial progenitor cells after acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; C-Reactive Protein; Endothelium, Vascular; Female; Flow Cytometry; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Prospective Studies; Ramipril; Stem Cells; Telmisartan | 2009 |
Differential levels of circulating progenitor cells in acute coronary syndrome patients with a first event versus patients with recurring events.
Topics: AC133 Antigen; Acute Coronary Syndrome; Aged; Angiotensin-Converting Enzyme Inhibitors; Antigens, CD; Antigens, CD34; Benzimidazoles; Benzoates; C-Reactive Protein; Female; Flow Cytometry; Glycoproteins; Hematopoietic Stem Cells; Humans; Linear Models; Male; Middle Aged; Peptides; Prospective Studies; Ramipril; Recurrence; Telmisartan | 2011 |